Thomas C. Ransohoff, M.S is currently Managing Director at the BioProcess Technology Group at BDO USA, LLP and has over 30 years of experience in the biopharmaceutical industry. Mr. Ransohoff's areas of expertise include development and scale-up of biopharmaceutical processes; separations and purification technologies; cGMP manufacturing; and management of technology-based start-up ventures. Before joining BDO, Mr. Ransohoff held senior level positions at BPTC, TranXenoGen, Dyax, Repligen, and Xoma. He is also a co-founder of both Tarpon Biosystems and BioFlash Partners. He serves on a number of scientific and professional advisory boards and holds a Bachelor's degree from MIT and a Master's degree from the University of California, Berkeley, both in Chemical Engineering.